Difference between revisions of "Transfusion"
Line 39: | Line 39: | ||
VT - Accept if transfused in UK, Europe, Australia, North America AND inform Transplant Centre. If transfused outside these regions discuss case with MO | VT - Accept if transfused in UK, Europe, Australia, North America AND inform Transplant Centre. If transfused outside these regions discuss case with MO | ||
+ | UNACCEPTABLE: | ||
− | |||
+ | 1. At any time the donor has: | ||
+ | |||
+ | a) Received, or thinks they may have received, a transfusion of blood or | ||
+ | blood components in a country endemic for malaria or South American | ||
+ | trypanosomiasis. See ‘Discretionary’ section below for exceptions. | ||
+ | |||
+ | b) Has received regular treatment with blood derived coagulation factor | ||
+ | concentrates. | ||
+ | Treated with blood derived coagulation factor concentrates. This includes | ||
+ | prothrombin complex to reverse over-anticoagulation. | ||
+ | |||
+ | 2. Since January 1st 1980: | ||
+ | |||
+ | a) Anywhere in the world, the donor has received, or thinks they may have | ||
+ | received, a transfusion with red cells, platelets, fresh frozen plasma (FFP), | ||
+ | cryoprecipitate, intravenous or subcutaneous human normal | ||
+ | immunoglobulin. This includes mothers whose babies have required intrauterine | ||
+ | transfusion. | ||
+ | |||
+ | b) Had a plasma exchange performed. | ||
+ | |||
+ | 3. Before January 1st 1999: | ||
+ | |||
+ | Treated with prothrombin complex to reverse over-anticoagulation | ||
+ | |||
+ | For the rest of the case, follow current JPAC guidelines in conjunction with transplant centre: | ||
[http://www.transfusionguidelines.org/dsg/bm/guidelines/tr014-transfusion JPAC Transfusion Guidelines] | [http://www.transfusionguidelines.org/dsg/bm/guidelines/tr014-transfusion JPAC Transfusion Guidelines] | ||
+ | |||
==Pseudonyms or Related Conditions== | ==Pseudonyms or Related Conditions== |
Revision as of 09:38, 18 June 2018
Contents
Acceptability at Recruitment
QUALIFIED
Acceptability at CT / Work-Up
QUALIFIED
Individual at Risk
Recipient
Explanation of Condition
Includes transfusion with :
red blood cells
platelets
fresh frozen plasma (FFP)
cryoprecipitate
buffy coat/white cell/neutrophils
intravenous or subcutaneous human normal immunoglobulin
Guidance
Establish:-
What blood component the donor received?
In which country the transfusion was given?
Which year the transfusion was given?
RECRUITMENT - Accept if transfused in UK, Europe, Australia, North America. If transfused outside these regions discuss case with MO
VT - Accept if transfused in UK, Europe, Australia, North America AND inform Transplant Centre. If transfused outside these regions discuss case with MO
UNACCEPTABLE:
1. At any time the donor has:
a) Received, or thinks they may have received, a transfusion of blood or blood components in a country endemic for malaria or South American trypanosomiasis. See ‘Discretionary’ section below for exceptions.
b) Has received regular treatment with blood derived coagulation factor concentrates. Treated with blood derived coagulation factor concentrates. This includes prothrombin complex to reverse over-anticoagulation.
2. Since January 1st 1980:
a) Anywhere in the world, the donor has received, or thinks they may have received, a transfusion with red cells, platelets, fresh frozen plasma (FFP), cryoprecipitate, intravenous or subcutaneous human normal immunoglobulin. This includes mothers whose babies have required intrauterine transfusion.
b) Had a plasma exchange performed.
3. Before January 1st 1999:
Treated with prothrombin complex to reverse over-anticoagulation
For the rest of the case, follow current JPAC guidelines in conjunction with transplant centre:
Pseudonyms or Related Conditions
Blood transfusion
Version
Version 1, Edition 2
Date of Last Update
3 November 2016